MarketCap
Facebook
X
Telegram
INmune Bio Kurzfristige Verbindlichkeiten | INMB
Kurzfristige Verbindlichkeiten Jährlich INmune Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.42 M | 7.22 M | 18.5 M | 10.9 M | 4.36 M | 1.78 M | 700 K | 824 K | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18.5 M | 700 K | 6.58 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Achieve Life Sciences
ACHV
|
9.08 M | $ 6.75 | 5.8 % | $ 294 M |  USA |
 |
Amgen
AMGN
|
25.5 B | $ 460.27 | 0.28 % | $ 248 B | USA |
 |
Armata Pharmaceuticals
ARMP
|
8.95 M | $ 3.37 | 12.33 % | $ 122 M | USA |
 |
Axsome Therapeutics
AXSM
|
379 M | $ 132.34 | 1.95 % | $ 6.58 B | USA |
 |
Champions Oncology
CSBR
|
19.9 M | $ 4.8 | 0.85 % | $ 66.4 M | USA |
|
Forte Biosciences
FBRX
|
20.8 M | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Immunic
IMUX
|
30.6 M | $ 7.79 | 6.42 % | $ 1.21 B | USA |
 |
Aldeyra Therapeutics
ALDX
|
27.8 M | $ 0.64 | 4.12 % | $ 38.4 M | USA |
 |
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Precision BioSciences
DTIL
|
8.91 M | $ 10.62 | 7.6 % | $ 136 M | USA |
 |
AIM ImmunoTech
AIM
|
6.22 M | $ 0.16 | 4.41 % | $ 259 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
278 M | $ 67.32 | -3.3 % | $ 1.35 B | USA |
 |
Actinium Pharmaceuticals
ATNM
|
7.97 M | $ 1.42 | 9.23 % | $ 44.3 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
73.4 M | $ 1.29 | 2.38 % | $ 343 M |  Britain |
 |
BridgeBio Pharma
BBIO
|
288 M | $ 74.28 | 0.01 % | $ 14.2 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
196 M | $ 7.69 | 0.72 % | $ 1.61 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
57 M | $ 3.6 | 3.45 % | $ 249 M | Britain |
 |
Coherus BioSciences
CHRS
|
140 M | $ 0.77 | 2.9 % | $ 90.2 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
130 M | $ 25.59 | -5.24 % | $ 3.26 B | USA |
 |
BeyondSpring
BYSI
|
13.6 M | $ 0.61 | -3.32 % | $ 25.1 M | USA |
 |
Alkermes plc
ALKS
|
543 M | $ 45.88 | 3.01 % | $ 7.56 B |  Irlanda |
 |
Altimmune
ALT
|
15 M | $ 2.09 | 6.09 % | $ 184 M | USA |
 |
Cardiff Oncology
CRDF
|
16.4 M | $ 0.8 | 5.3 % | $ 53.5 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
44.9 M | $ 0.55 | -1.2 % | $ 6.09 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
36.4 M | $ 10.35 | 10.52 % | $ 283 M |  Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
195 M | $ 58.16 | 1.22 % | $ 7.78 B | USA |
 |
Incyte Corporation
INCY
|
1.52 B | $ 119.79 | 1.51 % | $ 23.4 B | USA |
 |
Atara Biotherapeutics
ATRA
|
14.9 M | $ 7.81 | -1.88 % | $ 98 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
93.7 M | $ 16.32 | 0.68 % | $ 2.19 B | Canada |
 |
Cullinan Management
CGEM
|
37.7 M | $ 11.37 | 5.28 % | $ 685 M | USA |
 |
Collegium Pharmaceutical
COLL
|
440 M | $ 24.19 | -3.86 % | $ 766 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
20.7 M | $ 3.07 | 7.34 % | $ 40.9 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
9.02 M | $ 1.26 | -0.79 % | $ 57.6 M | Israel |
 |
AnaptysBio
ANAB
|
35.4 M | $ 46.46 | 1.92 % | $ 1.35 B | USA |
 |
Assembly Biosciences
ASMB
|
48.8 M | $ 20.43 | 2.17 % | $ 229 M | USA |
 |
Adagene
ADAG
|
25.2 M | $ 1.99 | -1.73 % | $ 117 M |  China |
 |
Benitec Biopharma
BNTC
|
5.34 M | $ 9.51 | 10.07 % | $ 443 M | USA |
 |
Denali Therapeutics
DNLI
|
98.4 M | $ 20.09 | 1.88 % | $ 3.47 B | USA |
 |
Amarin Corporation plc
AMRN
|
194 M | $ 11.55 | -0.2 % | $ 4.79 B | Irlanda |
 |
Editas Medicine
EDIT
|
46.2 M | $ 2.57 | 0.59 % | $ 228 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
82.2 M | $ 29.4 | 4.0 % | $ 1.7 B | USA |
 |
Cue Biopharma
CUE
|
13.5 M | $ 18.93 | 5.11 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
2.93 M | $ 1.54 | 15.79 % | $ 88.2 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
15.7 M | $ 1.73 | 4.22 % | $ 98.4 M | USA |
 |
Pliant Therapeutics
PLRX
|
16.4 M | $ 0.81 | -0.12 % | $ 49.7 M | USA |